Dihydromyricetin Ameliorates Myocardial Ischemia-Reperfusion Injury by Modulating CKLF1-Mediated Cardiomyocyte Pyroptosis
{{output}}
Myocardial ischemia-reperfusion injury (MIRI) remains a major clinical challenge due to limited therapeutic options and the risk of complications such as hemorrhage. Dihydromyricetin (DMY), a flavonoid derived from Vine tea, has shown cardioprotective effects,... ...